Skip to content

Motivational Interviewing Effect on Reducing Cardiovascular Disease Risk Factors

Motivational Interviewing Based Training Program in Adults Effect on Reducing Cardiovascular Disease Risk Factors: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06071351
Enrollment
40
Registered
2023-10-06
Start date
2023-10-01
Completion date
2024-03-21
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Motivation, Nurse's Role, Risk Reduction

Keywords

cardiovascular disease, motivational interviewing, risk reduction, nurse's role

Brief summary

Aim: The aim of this study is to examine the effect of motivational interviewing-based training program on reducing cardiovascular disease risk factors in adults. Methods: In the first stage, individuals' CVD risk levels were determined. In the second stage, a 6-session motivational interview-based training program was applied to the intervention group with a medium CVD risk level (HearthSCORE score between 2 and 5 points). Brochures were distributed to the control group.

Detailed description

The aim of this study is to determine the CVD risks of adult individuals between the ages of 40-70 and to evaluate the effect of a motivational interview-based training program on reducing modifiable risk factors in individuals with moderate CVD risk. Hypothesis; A 6-session motivational interview-based training program aimed at reducing CVD risk factors reduces the risk level in the intervention group more than the control group. This study will be carried out in 2 stages. In the first phase, risk prevalence screening will be carried out to determine the CVD risks of individuals between October and November 2023. In the 2nd phase, a randomized controlled study will be conducted to evaluate the intervention program for individuals at medium risk level (HeartScore® between 2 and 5).

Interventions

OTHERmotivational interviewing based training program

In addition to the informative brochure prepared by the researcher; A 6-session training program based on motivational interviewing, including nutrition, physical activity, smoking and alcohol use, will be held.

An informative brochure prepared by the researcher was given.

Sponsors

Muş Alparslan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

single blind

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Being aged between 40 and 70 years, * Being voluntary to participate in the study,

Exclusion criteria

* Having a known and diagnosed CVD * Not being voluntary to participate in the study.

Design outcomes

Primary

MeasureTime frameDescription
change is CVD risk level24 weekIn the first phase of the research, the HeartScore® program will be used to determine the CVD risk levels of individuals. Thanks to this program, the CVD risk levels of individuals will be learned and primary protection will be provided. According to HeartScore®, CVD risk is discussed in 4 categories. * 10%, very high risk, * 5% - \<10%, high risk, Medium risk between ≥2-\<5%, If \<1%, they are in the low risk category. As the score increases, the CVD risk level increases.

Secondary

MeasureTime frameDescription
Change in Physical Activity Level24 weekPhysical activity level was measured using the International Physical Activity Questionnaire Short Form (IPAQ). Sitting 1.5 MET Walking 3.3 MET Moderate Intensity Physical Activity 4.0 MET Vigorous Physical Activity 8.0 MET Short form (7 questions); It provides information on time spent awake, moderate to vigorous intensity activities, and time spent sitting. The IPAQ categorically classifies individuals as inactive, minimally active, and very active.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026